Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Post by Trademark11on Aug 17, 2021 6:01am
268 Views
Post# 33715614

Organic Growth revisited

Organic Growth revisitedQ3/21 should give us a better view on their organic growth. 

No aquisitions in Q3/21, and will have an extra 400-500G contribution from Mayhews. 

If it organic growth sits at 8-10% annualized as suggested by management, then we should see Q/Q rate of 2-2.5%

As such:

Q2/21 Rev = 24.2
Mayhews   = 0.4-0.5 MM above Q2/21
Organic Growth = 2-2.5% Q/Q =  0.6-0.65MM 

Total Rev Q3/21 = 25.1-25.3 MM = 30% yr/yr growth

EBITDA @ 22%  = 5.4-5.6 MM 

Pretty much plain vanilla for this Q; pays to be patient in this case with an upside bias IMO, am trimming only slightly into the rallies
<< Previous
Bullboard Posts
Next >>